ORG Partners’s Pfizer PFE Stock Holding History

ORG Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$127K	Buy	5,107 +337	+7%	+$8.5K	0.02%	407
2025 Q3	$122K	Buy	4,770 +757	+19%	+$18.7K	0.02%	425
2025 Q2	$99.7K	Buy	4,013 +593	+17%	+$13.8K	0.02%	435
2025 Q1	$84.8K	Sell	3,420 -47,459	-93%	-$1.24M	0.02%	412
2024 Q4	$1.35M	Buy	50,879 +2,967	+6%	+$80.5K	0.18%	95
2024 Q3	$1.39M	Buy	47,912 +884	+2%	+$25.8K	0.22%	83
2024 Q2	$1.33M	Buy	47,028 +44,458	+1,730%	+$1.22M	0.17%	121
2024 Q1	$71.3K	Sell	2,570 -30,530	-92%	-$847K	0.14%	105
2023 Q4	$953K	Buy	33,100 +7,546	+30%	+$228K	0.16%	120
2023 Q3	$848K	Sell	25,554 -2,022	-7%	-$71.5K	0.25%	101
2023 Q2	$1.01M	Buy	27,576 +238	+0.9%	+$9.26K	0.16%	121
2023 Q1	$1.13M	Buy	+27,338	New	+$1.18M	0.28%	69

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ORG Partners's PFE Position: Q4 2025 in Review

ORG Partners increased its Pfizer (PFE) stake by 7.1% in Q4 2025, buying an estimated $8.5K and bringing the position to 5,107 shares worth $127K. The position accounts for 0.02% of the portfolio, ranked #407.

ORG Partners first reported a position in PFE in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.39M in Q3 2024. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

ORG Partners held 5,107 shares of Pfizer worth $127K as of Q4 2025.
ORG Partners bought 337 Pfizer shares in Q4 2025, an estimated $8.5K.
Pfizer made up 0.02% of ORG Partners's portfolio in Q4 2025, its #407 holding.
ORG Partners first reported a position in Pfizer in Q1 2023 and has held it in 12 quarters since.
ORG Partners's Pfizer position peaked at $1.39M in Q3 2024.
2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.